MET and hepatocellular carcinoma: Given c-Met’s established role in cellular processes and its activation of PI3K/AKT and MAPK pathways upon HGF binding, [30] which aligns with our transcriptomic enrichment analysis showing HHLA2 overexpression in HCC, we further investigated this interaction.